Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and Safety Results from a Phase 3 Study of Biosimilar Candidate ABP 710 in Subjects with Moderate to Severe RA Genovese, M., Sanchez-Burson, J., Balazs, E., Everding, A., Oh, M., Fanjiang, G., Cohen, S. WILEY. 2019
View details for Web of Science ID 000507466900521